N
ASXC

Natixis’s Asensus Surgical, Inc. ASXC Stock Holding History

Natixis’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-21,180
Closed -$655K – 926
2019
Q1 		$655K Sell
21,180
-1,885
-8% -$63.2K ﹤0.01% 638
2018
Q4 		$678K Buy
23,065
+2,654
+13% +$121K 0.01% 556
2018
Q3 		$1.54M Buy
+20,411
New +$1.38M 0.01% 517

Other funds holding ASXC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Natixis's ASXC Position: Q2 2019 in Review

Natixis sold out of Asensus Surgical, Inc. (ASXC) in Q2 2019, closing a stake of 21,180 shares — an estimated $655K sold.

Natixis first reported a position in ASXC in Q3 2018 and held it in 3 quarters. The position peaked at $1.54M in Q3 2018. 141 funds tracked by Wall St. Rank hold ASXC as of Q2 2019.

  • Natixis reported no remaining Asensus Surgical, Inc. position as of Q2 2019 after selling out during the quarter.
  • Natixis sold 21,180 Asensus Surgical, Inc. shares in Q2 2019, an estimated $655K.
  • Natixis first reported a position in Asensus Surgical, Inc. in Q3 2018 and held it in 3 quarters.
  • Natixis's Asensus Surgical, Inc. position peaked at $1.54M in Q3 2018.
  • 141 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2019.

Based on Natixis's 13F filing for Q2 2019, filed 13 Aug 2019.